Nuevocor operates as a preclinical-stage biotech company. Founded by Brian Burke, Colin Stewart, Jianming Jiang, Mark Kay, Yann Chong Tan, and Yin Loon Lee in 2020, Nuevocor is backed by investors that include EDBI, Seeds Capital, Boehringer Ingelheim Venture Fund, Xora Innovation, and EVX Ventures and is headquartered in Singapore.